Alembic Pharma Shares Surge 2% on USFDA Final Approval
Shares of Alembic Pharmaceuticals Ltd surged more than 2% on 28 July after the company announced securing final approval from the USFDA for Carbamazepine Extended-Release...
Tag : US Food & Drug Administration (USFDA)
Dr Reddy’s Secured EIR for New York API Facility; Shares Slump 1%
Shares of Dr Reddy’s Laboratories Ltd were trading in the red and 1% lower on 22 July despite the company announcing it had obtained the...
Lupin Shares Gain 1% on USFDA Approval
Shares of Lupin Ltd were trading in the green and 1% higher on 2 July after the company announced receiving approval from the USFDA for...
Alembic Pharma Shares Skyrocketed 14% on USFDA Final Approval
Shares of Alembic Pharmaceuticals Ltd skyrocketed more than 14% on 30 June after the company announced on Sunday that it had received final USFDA approval...
SMS Pharma Shares Surge 6% on 0 Observations from USFDA
Shares of SMS Pharmaceuticals Ltd surged 6% on 26 June after the company announced receiving no observations from the US Food and Drug Administration (USFDA)....
JB Chemicals Shares Gain 2% on USFDA Approval
Shares of JB Chemicals and Pharmaceuticals Ltd were trading in the green and 2% higher on 25 June after the business received USFDA approval for...
Granules India Shares Gain 2% on 1 Observation from USFDA
Shares of Granules India Ltd were trading 2% higher on 23 June after the company announced receiving one observation from the US FDA for its...
Natco Pharma Shares Fall 1% on 7 USFDA Observations
Shares of Natco Pharma Ltd were trading in the red and 1% lower on 20 June after the company received seven Form-483 observations from the...
Alembic Pharma Secures EIR from USFDA
Alembic Pharmaceuticals Ltd announced on Wednesday, 18 June, that it received an Establishment Inspection Report (EIR) from the US Food and Drug Administration (USFDA) for...
Syngene International Shares Gain 1% on Zero Observations
The share price of Syngene International Ltd rose 1% in early trading on 16 June following zero observations by the United States Food and Drug...